Please provide your email address to receive an email when new articles are posted on . Older patients with atrial fibrillation were more likely to have high bleeding risk contraindications with oral ...

Many patients with atrial fibrillation are not taking oral anticoagulation because of an elevated bleeding risk, and this subset faces substantial risks of both ischemic and hemorrhagic stroke, a new ...

An analysis of the ongoing SAGE-AF trial revealed that approximately 23% of geriatric patients with atrial fibrillation and prescribed a direct oral anticoagulant received inappropriate dosing. Most ...

Atrial fibrillation patients with mental health conditions are less likely to be eligible for warfarin receipt, and those who are eligible receive warfarin at lower rates. Objectives: To characterize ...

It is uncommon for hospitalized older adults newly diagnosed with atrial fibrillation to start anticoagulation therapy. In fact, only about 25% overall begin taking these medications soon after ...

A new multicenter study in the United States has found that use of thromboprophylaxis in hospitalized cancer patients is now much higher (74%) than has been previously reported, but it also found that ...

In order to answer this question, an individual patient's bleeding risk must be weighed against his thromboembolic risk. This risk assessment will be different in each patient. In general, if a ...

Most patients with pulmonary embolism (i.e., low-risk, intermediate–low-risk, and most intermediate–high-risk) are adequately managed with anticoagulation alone. Selected intermediate–high-risk ...

A new study suggests almost 40,000 patients with an irregular heartbeat are being treated with anti-coagulants, even though they are at risk of adverse effects. GPs are recommended to prescribe ...

In a population largely consisting of patients with nonvalvular A-fib who have contraindications to warfarin therapy, implantation of the Watchman left atrial appendage (LAA) closure device appears ...